HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ganglidiomab

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Brackrock, Diana: 2 articles (12/2013 - 06/2013)
2.	Lode, Holger N: 2 articles (12/2013 - 06/2013)
3.	Reker, Daniel: 2 articles (12/2013 - 06/2013)
4.	Schmidt, Manuela: 2 articles (12/2013 - 06/2013)
5.	Seidel, Diana: 2 articles (12/2013 - 06/2013)
6.	Siebert, Nikolai: 2 articles (12/2013 - 06/2013)
7.	Eger, Christin: 1 article (12/2013)
8.	Bleeke, Matthias: 1 article (06/2013)
9.	Brandt, Sven: 1 article (06/2013)
10.	Helm, Christiane: 1 article (06/2013)

Related Diseases

1.

06/01/2013 - "Finally, we demonstrated induction of a GD(2)-specific humoral immune response after vaccination of mice with ganglidiomab effective in mediating GD(2)-specific killing of neuroblastoma cells. "
11/25/2022 - "Immune Response and Outcome of High-Risk Neuroblastoma Patients Immunized with Anti-Idiotypic Antibody Ganglidiomab: Results from Compassionate-Use Treatments."
06/01/2013 - "We generated and characterized a novel anti-idiotype antibody ganglidiomab and demonstrated activity against neuroblastoma."
06/01/2013 - "Vaccination with anti-idiotype antibody ganglidiomab mediates a GD(2)-specific anti-neuroblastoma immune response."
12/15/2013 - "Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab."

Related Drugs and Biologics

1.	Antigens
2.	Antibodies
3.	dinutuximab